tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market

Pacira Pharmaceuticals (PCRX) Income Statement

Compare
361 Followers

Pacira Pharmaceuticals Income Statement

Last quarter (Q3 2024), Pacira Pharmaceuticals's total revenue was $168.57M, an increase of 2.83% from the same quarter last year. In Q3, Pacira Pharmaceuticals's net income was $-143.47M. See Pacira Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 674.98M$ 666.82M$ 541.53M$ 420.83M$ 421.03M
Gross Profit
$ 490.31M$ 467.53M$ 401.28M$ 303.50M$ 314.31M
Operating Expenses
$ 402.63M$ 396.60M$ 268.44M$ 260.80M$ 278.60M
Depreciation and Amortization
$ 75.57M$ 91.50M$ 28.55M$ 19.91M$ 19.58M
EBITDA
$ 157.58M$ 144.78M$ 118.47M$ 71.42M$ 55.29M
Operating Income
$ 87.67M$ 60.02M$ 131.06M$ 46.35M$ 38.11M
Other Income/Expenses
$ -25.97M$ -46.72M$ -33.52M$ -26.26M$ -26.66M
Pretax Income
$ 61.70M$ 13.30M$ 56.40M$ 20.09M$ -10.75M
Net Income
$ 41.95M$ 15.91M$ 41.98M$ 145.52M$ -11.02M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.91$ 0.35$ 0.95$ 3.41$ -0.27
Diluted EPS
$ 0.81$ 0.34$ 0.92$ 3.33$ -0.27
Weighted Average Shares Outstanding
46.22M 45.52M 44.26M 42.67M 41.51M
Weighted Average Shares Outstanding (Diluted)
51.98M 46.54M 45.63M 43.68M 41.51M
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis